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Vitiligo is an acquired pigmentary dis-
order characterized by the development
of depigmented lesions in a variable
distribution, owing to the loss or
destruction of functioning melanocytes
(Guerra et al., 2010). Complex interac-
tions between genetic, immunological,
biochemical, and environmental factors
are likely to be related to the develo-
pment of vitiligo (Malhotra and Dytoc,
2013). Despite having identified multiple
risk factors of vitiligo, the molecular
mechanisms of its pathogenesis remain
obscure.
In a recent genome-wide association
study for generalized vitiligo in the
Chinese Han population, the gene
encoding ribonuclease (RNASE) T2 at
6q27 was identified as a disease risk
factor (Quan et al., 2010); however, the
functional roles of RNASET2 in vitiligo
pathogenesis have yet to be determined.
RNASET2 is the only human member of
the Rh/T2/S family of acidic hydrolases
(Campomenosi et al., 2006). The ribo-
nucleases are ubiquitous, conserved
enzymes with a broad spectrum of
normal physiological functions. Studies
concerning RNASET2 first focused on
its antitumorigenic characteristics. A
decreased expression of RNASET2 was
found in different types of tumor tissues
(e.g., ovarian cancer, melanoma cancer,
lymphoma, and so on), and both in vitro
and in vivo studies showed that
RNASET2 could inhibit the prolife-
ration of several tumor cells, indicating
the possible role of RNASET2 as a tumor
suppressor gene (Acquati et al., 2001;
Monti et al., 2008; Acquati et al., 2013).
Notably, the hyperexpression of
RNASET2 at the tumor sites was
accompanied by abundant infiltration
of monocyte/macrophages. In mice
models pretreated with the macrophage-
depleting agent clodronate, the tumor-
suppressing activity of RNASET2 turned
out to be largely impaired (Acquati
et al., 2011; Acquati et al., 2013), yet
inactivating its RNase activity did not
affect its tumor-suppressive properties
(Smirnoff et al., 2006). Taken together,
we propose that RNASET2 may exert its
antitumor effects by promoting immune
response against tumors. On the other
hand, RNASET2 has also recently been
shown to take part in the stress response.
RNASET2 is typically secreted from the
cell or localized to internal com-
partments under normal conditions
(Thompson and Parker, 2009). However,
in the presence of oxidative stress,
RNASET2 proteins would enter the
cytoplasm. For example, the RNASET2
ortholog in Saccharomyces cerevisiae,
Rny1, was released from the vacuole
into the cytosol during oxidative stress
and promoted cell death during oxida-
tive stress independently of its catalytic
activity (Thompson and Parker, 2009).
Although the precise etiology of viti-
ligo remains uncertain, most researchers
agree that autoimmune and oxidative
stress greatly contribute to precipitating
the disease (Laddha et al., 2013).
Vitiligo lesions are characterized by an
infiltration of CD4þ helper T cells and
CD8þ cytotoxic T lymphocytes (Steitz
et al., 2005; van den Boorn et al., 2009).
Anti-melanocyte antibodies are detected
in the sera of vitiligo patients (Kemp
et al., 2007; Kemp et al., 2011;
Sandoval-Cruz et al., 2011). Certain
known stressors including ultraviolet (UV)
irradiation, mechanical injuries, and
inflammation can cause depigmenta-
tion in previously normal skin or invoke
a Koebner phenomenon in about half of
the patients (van Geel et al., 2012).
Therefore, it is of great interest to iden-
tify the molecular connection between
oxidative stress and autoimmune
response. As RNASET2 has the dual
functions in both autoimmune and
oxidative stress responses, we asked
how to define the involvement of
RNASET2 in the pathogenesis of vitiligo?
According to the ‘‘danger theory’’
by Matzinger (2002), when a cell is
stressed, even in the absence of any
foreign substance, it emits molecules as
‘‘alarm signals’’ to activate immune
cells and initiate an immune response.
This theory establishes a synergistic
interaction of oxidative stress with
immune response and provides new
insights. A lot of those ‘‘alarm signals’’
have been determined, such as heat-
shock proteins (Vabulas et al., 2002)
and high-mobility group box 1 (Park
et al., 2006). To investigate the patho-
genesis of vitiligo, we hypothesize that
RNASET2 might act as an ‘‘alarm
signal’’ in the development of vitiligo.
The risk factors of vitiligo, such as
peroxides, UV exposure, injuries, or
inflammation, will cause damage to
the melanocytes or keratinocytes. And
those cells under stress conditions will
release RNASET2 as ‘‘alarm signals’’
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into the immediate environment to alarm
the immune system. On one hand,
RNASET2 might directly inhibit the
growth of melanocytes. On the other
hand, RNASET2 might act as an endo-
genous ligand to activate antigen-pre-
senting cells, for example, dendritic cells,
thus initiating an immune response
against melanocytes (Figure 1).
In order to test our hypothesis, we
investigated the expression of RNASET2
in vitiligo lesions as well as its molecu-
lar functions involving apoptosis-related
signaling proteins and pathways. We
found an overexpression of RNASET2
in epidermis of vitiligo patients com-
pared with the healthy controls. In vitro
analyses indicated that the overexpres-
sion of RNASET2 was inducible in
cultured primary human melanocytes
and keratinocytes by stress conditions
such as UV irradiation, hydrogen
peroxide, and inflammatory factors.
In silico analysis of the RNASET2
amino-acid sequence identified a puta-
tive binding motif for the tumor necrosis
factor receptor-associated factor 2
(TRAF2), which has recently been iden-
tified as a threshold determinant factor
of apoptosis through its ubiquitin ligase
activities acting upon caspase-8. This
finding becomes particularly intriguing
when taking into account that biopsies
of vitiligo lesions have revealed that
apoptosis, rather than cell death, was
the main cause for the melanocyte loss.
Therefore, we further analyzed the
interaction of TRAF2 and RNASET2.
We demonstrated that RNASET2 indeed
led to enhanced cell apoptosis via the
TRAF2 caspases pathway through the
physical interaction of RNASET2 and
TRAF2. Thus, RNASET2 may contribute
to the development of vitiligo by inhibit-
ing TRAF2 expression and lead directly
to apoptosis of melanocytes (Wang
et al., 2014).
Apart from that, autoimmunity is
another key factor involving in the
pathogenesis of vitiligo. Although as
yet there is no study about the immu-
nological functions of RNASET2, it was
recently shown that omega-1, an RNa-
seT2 family member secreted from the
eggs of Schistosoma mansoni, could
induce Th2 polarization by priming
dendritic cells (Everts et al., 2012). It
will be our goal to determine whether
or not human RNASET2 has similar
effects and is therefore involved in the
pathogenesis of vitiligo. Future studies
concerning the immunological func-
tions of RNASET2 and its role linking
oxidative stress and immune response
may allow the development of novel
therapies for vitiligo.
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Figure 1. ‘‘RNASET2 alarm signal’’ hypothesis in vitiligo.
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